Neonatal Abstinence Syndrome: Understanding, Management, and Impact
Received Date: Sep 02, 2024 / Published Date: Sep 30, 2024
Abstract
Neonatal Abstinence Syndrome (NAS) is a withdrawal syndrome that occurs in newborns exposed to certain substances in utero, particularly opioids. As the opioid crisis continues to escalate, the prevalence of NAS has increased significantly, posing serious health challenges for affected infants and their families. This article examines the etiology, clinical manifestations, diagnosis, management strategies, and long-term outcomes associated with NAS. Understanding the complexities of this condition is essential for healthcare providers, caregivers, and policymakers to improve care for affected infants and address the broader societal issues linked to substance use during pregnancy.
Citation: Chloe J (2024) Neonatal Abstinence Syndrome: Understanding, Management, and Impact. Neonat Pediatr Med 10: 460
Copyright: © 2024 Chloe J. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Share This Article
Recommended Conferences
Toronto, Canada
Recommended Journals
黑料网 Journals
Article Usage
- Total views: 189
- [From(publication date): 0-0 - Mar 09, 2025]
- Breakdown by view type
- HTML page views: 153
- PDF downloads: 36